OTC Markets · Medical Devices · USD
Allurion Technologies Inc. (ALUR) Stock Analysis
Allurion Technologies Inc. (ALUR) is a Medical Devices stock listed on OTC Markets and quoted in US Dollar.
Last Updated: October 20, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
ALUR Key Statistics
As of Oct 20, 2026Trading
- Open
- $0.48
- Previous Close
- $0.48
- 52-Week Range
- 0.23–8.52
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- −0.13
Valuation
- Market Cap
- $288.63K
- P/E Ratio
- unprofitable
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 0.02
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −54.75
Financials (FY)
- Revenue (FY)
- $15.23M−52.57%
- Net Income (FY)
- −$28.76M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −264.74%
- Shares Outstanding
- 607.65K
- 1-Year Return
- −76.49%
Dividend and dates
- Avg Volume
- 2.66K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 20, 2026, ALUR closed at $0.48, −76.49% over 1 year.
Allurion Technologies Inc. (ALUR) has a market capitalization of $288.63K.
In fiscal 2025, ALUR reported revenue of $15.23M.
ALUR Stock Return by Calendar Year
Allurion Technologies Inc. (ALUR) return since Jan 2025: what $10,000 became
- 1 year
- $10,000 $2,351
- −76.49%
- Since Jan 2025
- $10,000 $1,243
- −87.57%
If you had invested $10,000 in Allurion Technologies Inc. (ALUR) at the close on January 10, 2025, the earliest close on record here, it would have been worth $1,243 at the close on October 20, 2026: −87.57% in total, −69.12% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −61.38% |
| 2025 | −67.80% |
As of October 20, 2026.
ALUR Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $15.23M | −$28.76M | −188.8% |
| 2024 | $32.11M | −$7.20M | −22.4% |
| 2023 | $53.47M | −$82.82M | −154.9% |
| 2022 | $64.21M | −$37.74M | −58.8% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $15.23M | $9.57M | −$30.16M | −$28.76M | −188.8% |
| 2024 | $32.11M | $21.50M | −$50.20M | −$7.20M | −22.4% |
| 2023 | $53.47M | $41.50M | −$79.08M | −$82.82M | −154.9% |
| 2022 | $64.21M | $50.73M | −$32.01M | −$37.74M | −58.8% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
ALUR Valuation vs Medical Devices Median
Median of 145 stocks| Metric | ALUR | Medical Devices median | vs median |
|---|---|---|---|
| P/S ratio | 0.02 | 2.53 | 0.0x the median |
| Profit margin | −264.74% | −14.78% | 250.0 pts below |
Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 20, 2026.
Related Medical Devices Stocks
Abbott Laboratories
$173.92B
MDTMedtronic plc.
$119.00B
SYKStryker Corporation
$114.15B
BSXBoston Scientific Corporation
$64.33B
EWEdwards Lifesciences Corporation
$50.95B
GEHCGE HealthCare Technologies Inc.
$31.17B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B